PD-L1, a key component of the tumor immune evasion mechanisms, is indeed highly expressed in many breast cancer patients' tumors, especially in cases with poorly activated tumor-infiltrating effector T lymphocytes (3). This evidence concerns the gene CD274 and breast cancer.